About Therapixel
Therapixel is a company based in Nice (France) founded in 2013 by Pierre Fillard. Therapixel has raised $22.09 million across 4 funding rounds from investors including Crédit Agricole, Caphorn and Inria. Therapixel offers products and services including MammoScreen. Therapixel operates in a competitive market with competitors including Change Healthcare, AIdoc, Cleerly, eCential Robotics and AI Medical Service, among others.
- Headquarter Nice, France
- Founders Pierre Fillard
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Therapixel
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$22.09 M (USD)
in 4 rounds
-
Latest Funding Round
$15.81 M (USD), Series B
May 12, 2022
-
Investors
Crédit Agricole
& 14 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Therapixel
Therapixel offers a comprehensive portfolio of products and services, including MammoScreen.
AI tool for enhancing breast cancer detection in mammograms.
People of Therapixel
Unlock access to complete
Funding Insights of Therapixel
Therapixel has successfully raised a total of $22.09M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $15.81 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Therapixel
Therapixel has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include Crédit Agricole, Caphorn and Inria.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth and acquisition investments are managed by Credit Mutuel Equity.
|
Locked | Locked | Locked | |
|
Venture capital investments are directed toward startups by Caphorn.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on science and tech-driven startups
|
Locked | Locked | Locked |
Investor details for Therapixel
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Therapixel
Investment portfolio details for Therapixel
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Therapixel
Detailed financials for Therapixel
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Therapixel Comparisons
Peer comparison for Therapixel
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Therapixel
Therapixel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Change Healthcare, AIdoc, Cleerly, eCential Robotics and AI Medical Service, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based solutions are delivered for healthcare payers, providers, and patients.
|
|
| Locked | Locked | Locked |
AI-based single-screen system is provided to streamline medical imaging.
|
|
| Locked | Locked | Locked |
Atherosclerotic plaque is quantified by AI using coronary CT angiograms.
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
Provider of AI-based solution for diagnosis of cancer related lesions
|
|
| Locked | Locked | Locked |
Provider of AI-based breast cancer screening software for clinics
|
Detailed competitors of Therapixel
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Therapixel
Complete news archive for Therapixel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Therapixel
Therapixel was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Therapixel is headquartered in Nice, France. It is registered at Nice, Provence-alpes-cote D'azur, France.
Pierre Fillard is the current CEO of Therapixel. They have also founded this company.
Therapixel is a funded company, having raised a total of $22.09M across 4 funding rounds to date.
Therapixel was founded in 2013 in Nice, France, as a provider of an analytics platform for medical image visualization and analysis in operating theaters. Machine learning algorithms are utilized to enhance breast cancer detection. Control is enabled through a motion sensor that interprets hand gestures as commands. The underlying technology stems from research conducted at INRIA, focusing on healthcare imaging solutions.
Therapixel's top competitors include Change Healthcare, AIdoc and eCential Robotics.
Therapixel offers MammoScreen.
Therapixel has 15 investors. Key investors include Crédit Agricole, Caphorn, Inria, Crédit Mutuel Equity, and Verve Ventures.